(HealthDay News) — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according ...

New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.

No significant increases seen in rate of hospital contacts for any of 29 adverse events in 28-day risk period after vaccination.

In solid organ transplant recipients (SOTRs) with advanced cancer treated with immune checkpoint inhibitors (ICIs), cancer outcomes and transplant rejection risk vary by cancer type, investigators ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

(HealthDay News) — Cardiovascular risk factor and disease mortality varies significantly among Asian Indian, Chinese, and Filipino Americans, with Filipino Americans having the highest mortality ...

(HealthDay News) — Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus (T2DM), according to a study ...

A randomized controlled trial tested a model using donor-derived cell-free DNA for predicting graft rejection.

(HealthDay News) — Having a supratherapeutic international normalized ratio (INR) while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older ...

About 1 in 6 patients with GG1 prostate cancer have a higher risk of prostate cancer-specific death, data suggest.

(HealthDay News) — Patients undergoing major surgery who experience alcohol withdrawal syndrome (AWS) and delirium tremens (DT) face significantly higher risks for complications, according to a study ...

Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head-to-head trials.